CN
931-97-5
应用筛选条件
关键词:'931-97-5'
显示 1-17 共 17 条结果 关于 "931-97-5" 范围 技术文档
Quality Control Range Sheet- MCC-115 and MCC-215
IL-4 Control 1 97 - 202 pg/mL KC Control 1 131 - 272 pg/mL IL-9 Control 1 90 - 220 pg/mL
Control 2 468 - 972 pg/mL Control 2 670 - 1392 pg/mL
Data Sheet - D4418
Clin. Exp. Pathol., 5(5),
1000243 (2015).
13. Dunn, K.J. et al., Proc. Nat. Acad. Sci. USA,
97(18), 10050-10055 (2000).
14. Shin, J.-W. et al., J. Comp. Neurol., 511(5),
628-657 (2008).
Periodic table Poster
3228
1.22
Pu
3, 4, 5, 6
[Rn] 5f67s2
95
*243.06
1176
2011
1.20
Am
3, 4, 5, 6
[Rn] 5f77s2
96
*247.07
1345
1.20
Cm
3, 4
Periodic table A4
3228
1.22
Pu
3, 4, 5, 6
[Rn] 5f67s2
95
*243.06
1176
2011
1.20
Am
3, 4, 5, 6
[Rn] 5f77s2
96
*247.07
1345
1.20
Cm
3, 4
Product Information Sheet - CS0090
Sci. USA,
97, 12103–12108 (2000).
5. Virkamaki, A., et al. Protein-protein interaction in
insulin signaling and the molecular mechanisms of
insulin resistance. J. Clin. Invest., 103, 931-943
(1999
Product Information Sheet - PI0200
Sci. USA, 97,
12103–12108 (2000).
5. Virkamaki, A., et al., Protein-protein interaction in
insulin signaling and the molecular mechanisms of
insulin resistance. J. Clin. Invest., 103, 931-943
(1999
Product Information Sheet - PI0100
Sci.
USA, 97, 12103–12108 (2000).
5. Virkamaki, A., et al., Protein-protein interaction in
insulin signaling and the molecular mechanisms of
insulin resistance. J. Clin. Invest., 103, 931-943
(1999
Halal Certificate
22SIA982
284. 4-METHYL-5-THIAZOLEETHANOL ACETATE 98%, FG W320501 B80093 HC-22SI7623
285. 4-METHYL-5-THIAZOLEETHANOL FG W320404 A45808 HC-22SIVG70
286. 4-METHYL-5-VINYLTHIAZOLE 97%, FG W331309 A77976
Halal Certificate
23SIBK61
284. 4-METHYL-5-THIAZOLEETHANOL ACETATE 98%, FG W320501 B80093 HC-23SIF602
285. 4-METHYL-5-THIAZOLEETHANOL FG W320404 A45808 HC-23SI4849
286. 4-METHYL-5-VINYLTHIAZOLE 97%, FG W331309 A77976
Product Information Sheet - INHIB1
32. Zhu, W-G., et al., Biochem. Biophys. Res.
Commun., 225(3), 924-931 (1996).
33. Sarin, A., et al., J. Exp. Med., 178(5), 1693-1700
(1993).
34. Hashida, S., et al., J. Biochem., 88(6), 1805
Calbiochem Biologics 29.2
Med. Chem. 10, 1587;
4. Soto, C., et al. 1998. Nat. Med. 4, 822; 5. Hetenyi, C., et al. 2002. Biochem. Biophys. Res. Commun. 292, 931; 6. Permanne, B., et al. 2002. FASEB J. 16, 860.
NEW! Antibodies
S&E Campaign Lab Tools - Tables for laboratory use
0.82 1 [Ar] 4s1 2.4 4.3407 -2.925 V (I)
Praseody-
mium
Pr 59 140.91 6.48 g/cm3 931 3520 182.4 1.07 1.13 3, 4 [Xe] 4f3 6s2 5 × 10-4 5.473 -0.96 V (IV),
-2.35 V (III)
Promethium Pm 61
Protein Depletion for Plasma and Serum Proteomic Analysis
Sequencing Consortium: Finishing
the euchromatic sequence of the human genome. Nature 2004,
431:931-945.
33. Anderson L, Seilhamer J: A comparison of selected mRNA
and protein abundances in human
BRAND Katalog EN
Cat. No.
50 GL 40 52 90 34/35 931 70
100 GL 40 64 110 34/35 931 72
250 GL 52 85 140 45/40 931 75
500 GL 52 108 180 45/40 931 80
Protocol- 03-0178-00
1 2 3 4 5 6 7 8 9 10 11 12 Analyte (pg/mL)
μg
IgG/mg
MP
μg
MP/well
A 931 1507 2270 2292 20
12.5
5
B
Antibody SourceBook, Sixth Edition, DIST version
€282
Anti-VEGF Receptor 1 Goat pAb ELISA, IB, PS human PC322L 100 µg €527
Anti-VEGF Receptor 2 (931-997) Rabbit pAb IB, IH, IP human, mouse 676�88 50 µl €231
Anti-VEGF Receptor 2 Mouse mAb (CH-11)
XP725 Worksheet for Lot Number 071M4826
MSH6 M2445924 5 4 2 4
925 5 4 2 5 MSH6 M2820
926 5 4 2 6 MSH6 M2820
927 5 4 2 7 MSK1 M5437
928 5 4 2 8 MSK1 M5437
929 5 4 3 1 MTA 2 M7569
930 5 4 3